Daiwa Securities Group Inc. Sells 383 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Daiwa Securities Group Inc. trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 31.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 849 shares of the financial services provider’s stock after selling 383 shares during the period. Daiwa Securities Group Inc.’s holdings in iShares Biotechnology ETF were worth $115,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Glass Jacobson Investment Advisors llc boosted its stake in shares of iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after buying an additional 122 shares during the last quarter. Values First Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $43,000. Tennessee Valley Asset Management Partners acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $44,000. Horizon Bancorp Inc. IN acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at about $44,000. Finally, Massmutual Trust Co. FSB ADV lifted its stake in iShares Biotechnology ETF by 164.2% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 225 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.7 %

Shares of NASDAQ:IBB opened at $126.49 on Friday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16. The company has a 50-day simple moving average of $134.27 and a 200 day simple moving average of $129.74.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.